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Several immunosuppressive regimens have been used to inhibit the immune
response in autoimmune disease and allograft rejection. In general the inhibition
interferes mainly with the two pathways involved in cellular immune response:
specific cell-mediated cytotoxicity and delayed-type hypersensitivity (DTH) , (1-
8). In both mechanisms, lymphokine production by T cells plays a crucial role;
lymphokines are essential for the proliferation and differentiation of cytotoxic
T cell precursors, as well as for the effector phase of DTH reactions. Lympho-
kines, such as interferons, are also potent inducers of MHC class I and class II
antigens (9-11), which both play a critical role in the development and augmen-
tation of the immune response (12-16). The inhibition of lymphokine production
e.g., IFN-y and IL-2 and the modulation of MHC antigen expression was shown
to be an important mode of action of immunosuppressive drugs such as steroids
(17, 18) and cyclosporin A (19, 20).
So far, treatment of autoimmune disease and allograft rejection is achieved by
systemic immunosuppression without specificity for the organs affected. Recently
however, controversy has increased concerning the role of systemic versus local
regulatory mechanisms in cellular immune response . Immune stimulation by
MHC antigen expression has been seen both as a local and systemic process in
autoimmune disease, as well as in allograft rejection (21-26) . The same contro-
versy holds true for the effector mechanisms during cellular immune response.
Originally it was proposed that sensitized cells mature within the central lymphoid
tissue and subsequently migrate as mature effector cells to the target tissue and
mediate tissue destruction (8, 27-29). More recently, however, it was demon-
strated that CTL could mature within sponge matrix allografts, which implies
an essential role for local development of CTL within the target organ, and
hence local production of lymphokines (30-32). In accordance with these obser-
vations, we recently demonstrated that intrarenal prednisolone delivery to rat
renal allografts was superior to systemic administration of the drug (33). These
data provide suggestive evidence for local regulation of the immune response
during allograft rejection and autoimmune disease. Moreover, they indicate that
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the local immune response within the affected organ is a favorable subject for
local immunosuppressive therapy. In this study we further analyze local regula-
tory mechanisms in graft rejection and their response to local immunosuppressive
therapy.
Materials and Methods
Animals.
￿
Inbred Brown Norway (RT") and Lewis (RT') male rats between 2 to 4 mo
of age were obtained from the Department of Experimental Animal Services of the
University of Limburg.
Experimental Model.
￿
Right kidneys were transplanted from Brown Norway (BN) to
Lewis rats using microsurgical techniques according to the method of Lee (34) with
modifications of Lameyer for ureter bladder anastomosis. Ischemia times were ^-30 min.
Recipient kidneys were both removed immediately after transplantation and graft survival
was assessed by animal survival. Recipient treatment consisted of prednisolone (Centra-
chemie, Etten-Leur, The Netherlands) administered by means of continuous infusion
either intrarenally or intraperitoneally. Continuous intrarenal drug delivery was per-
formed as described (33). Briefly, immediately after transplantation a catheter was
introduced into the suprarenal artery of the transplanted kidney. Because the suprarenal
artery in rat directly empties into the main renal artery, this method allows selective drug
administration to the graft without affecting renal blood flow. After potency of the
infusion system was checked the catheter was connected to an osmotic minipump (2ML2;
Alza, Palo Alto, CA) filled with the drug. Pumps were implanted into the abdominal
cavityand delivered prednisolone continuously from day 0 till day 13 after transplantation.
The technique used for intrarenal drug delivery showed by itself no significant effect on
renal allograft survival. Median graft survival time (MST) in animals treated with intra-
renal infusion of saline was 7 d (one for 6 d, five for 7 d, one for 8 d, and one for 12 d),
which was not significantly different from untreated controls (MST 8 d, two for 7 d, three
for 8 d, and two for 9 d). For continuous intraperitoneal infusion, pumps administered
prednisolone directly into the abdominal cavity. Prednisolone was dissolved in pyrogen-
free distilled water without heparin. The dose of the drug (4 mg/kg body wt/d) was
adjusted to body weight of the recipient the day before allografting was performed (day
-1). In animals that received intrarenal treatment, correct position of the catheter was
checked at autopsy.
Determination of Prednisolone Levels.
￿
Recipients were treated with prednisolone 4
mg/kg body wt/d given either by continuous intrarenal infusion or continuous intraperi-
toneal infusion. On day 3 after transplantation, blood was drawn and allografts were
excised for analysis of prednisolone levels. Prednisolone was analyzed with HPLC. The
method, as published by Rose and Jusko (35), was used with the following modifications.
Separation was performed on a 250 X 4.6 mm Lichrosorb 10-DIOL" column (Merck,
Darmstadt, Federal Republic of Germany). Eluent composition was: methylene dichloride,
73%; hexane, 25.5% ; methanol, 1 .5% (vol/vol). The coefficient of variation for prednis-
olone was ^-5%, the lower limit ofdetection was ^-10 ng/ml in serum.
Immunohistologic Studies. Renal allografts were excised on days 3, 7, and 12 after
transplantation. Immediately after harvesting, tissue samples were embedded in Tissue
TEK II (Miles Scientific, Naperville, IL) mounting medium and snap-frozen in isopentane
(-70'C). Cryostat sections of 5 /am were cut, air dried, fixed in acetone, and stored at
-20°C until used. Immunohistologic studies were performed using indirect immunoper-
oxidase staining. Briefly, slides were thawed at room temperature for 15 min, washed for
5 min in PBS, and then incubated with the appropriate mouse mAb for 30 min at room
temperature. Slides were washed again in PBS and subsequently incubated for 30 min
with horseradish peroxidase-coupled rabbit anti-mouse immunoglobulin (Dako, Copen-
hagen, Denmark) diluted 1 :100 in 10% rat serum. After washing in PBS, sections were
developed with a solution of 0.5 mg/ml diaminobenzidine tetrahydrochloride (Serva,
Heidelberg, Federal Republic of Germany) and 0.01 % H202 in 0.05 M Tris buffer, pH
7.6 . After 10 min slides were washed in tap water and counterstained with hematoxylin.RUERS ET AL.
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For parallel histologic observations, grafted tissue was fixed in neutral-buffered formalin,
processed in a routine manner, and hematoxylin and eosin-stained sections were exam-
ined.
Monoclonal Antibodies.
￿
The following mouse anti-rat mAb were used; MRC OX6 (36)
(Seralab, Crawley Down, United Kingdom) directed against rat MHC class II antigens.
This antibody reacts with inbred rat strains of the haplotypes L and N; His19 (37) reacts
with rat MHC class II antigens of the rat strains of haplotype L but not with antigens of
rat strains of the N haplotype. The antibody was kindly provided by Dr. Stet (Dept. of
Histology, University ofGroningen, The Netherlands). MRC OX 19 (38) (Seralab, Crawley
Down, United Kingdom) reacts with all rat T lymphocytes; W3/25 (39, 40) mainly
recognizes T helper cells but also stains a subpopulation of macrophages; OX8 (39, 41)
reacts with T cytotoxic/suppressor cells and a subpopulation of NK cells. ED2 (42)
recognizes rat macrophages; the antibody is directed against membrane antigens of tissue
macrophages, and has been described in detail by Dijkstra (Dept. of Histology, Free
University, Amsterdam, The Netherlands), who kindly provided the antibody. ART 18
(43) is directed against an antigenic determinant of the IL-2 receptor molecule in rat.
The antibody was kindly provided by Dr. Diamantstein (Dept. of Immunology, Klinikum
Steglitz, Berlin, Federal Republic of Germany). DB1 (44), reacting against rat IFN-y was
kindly provided by Dr. Van der Meide (Primate Centre, TNO Rijswijk, The Netherlands).
The antibody was prepared by fusing spleen cells from BALB/C mice immunized with
recombinant rat IFN-y with the myeloma SP20. The antibody was found to bind to rat
IFN-y in an ELISA and to block IFN-y activity in a virus-protection assay. All mAbs were
used at saturating dilutions of partially purified immune ascites. Normal kidney tissue
from BN and Lewis strain stained negative with mAbs ART18 (anti-IL-2-R) and DB1
(anti-IFN-y). Normal kidney tissue was almost devoid of ED2' cells (macrophages).
Morphometric Analysis ofTissue Sections.
￿
When indicated the cellular infiltration within
the grafts was quantified by morphometric analysis according to the method ofMcWhinnie
(45). Cellular infiltration within a section was assessed by point counting using a square
grid in the eyepiece of the microscope. The percentage area of each section occupied by
cells of a particular antigenic specificity was calculated as follows: Percentage area
infiltrated = 100 X (number of positive cells under grid intersections)/(total number of
grid intersections). The accuracy of the technique is proportional to the number ofpoints
counted. To maintain a standard errorof less than 10%, 4,250 points were counted when
density of the infiltrate was less than 10%, 600 points were counted when density of the
infiltrate was more than 10%. For point counting a 120 point or 850 point graticule was
used, within each section five fields were chosen at random and counted by a magnification
of X 400.
Results
Experimental Model for Local Immunosuppression.
￿
Allografts treated locally
with prednisolone 4 mg/kg body wt/d showed significant prolongation of graft
survival (MST, 28 d). As demonstrated in Table 1, local drug delivery resulted
in a mean kidney prednisolone level of 213 ng/kidney and a mean plasma level
of the drug of 53 ng/ml. To ascertain that, during intrarenal infusion, local
immunosuppression within the graft was responsible for the immunosuppressive
effect observed, recipients were treated intraperitoneally with the same dose of
prednisolone. Systemic administration of the drug resulted in an MST of 9 d,
which was not significantly different from control animals. During intraperitoneal
drug delivery the mean plasma prednisolone level was 46 ng/ml. The mean
kidney prednisolone level was 126 ng/kidney. These data demonstrate that the
systemic plasma level reached during local drug delivery is by itselfnot sufficiently
immunosuppressive to induce graft survival. From these observations it can be
concluded that during intrarenal treatment, high kidney prednisolone levels and1208
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TABLE I
Graft Survival andMean Prednisolone Levels in Plasma and Renal Allografts during
Continuous Delivery ofPrednisolone Intrarenally or Intraperitoneally
Therapy
Mean (±SD) prednisolone level
on day 3
Plasma
￿
Renal allograft
MST* n
ng/ml ng/kidney d
4 mg/kg Continuously intraperitoneally
￿
46 ± 8
￿
126 ± 21
￿
9
￿
9
4 mg/kg Continuously intrarenally
￿
53 t 14$
￿
213 f 80$
￿
281 ￿9
* MST, median graft survival time as determined in graftsurvival studies. MST in untreated controls
is 8 d.
$ Wilcoxon rank test for difference between plasma prednisolone levels in animals treated intraperi-
toneally and intrarenally is not significant.
$ Wilcoxon rank test fordifference between prednisolone levels in renalallografts ofanimals treated
intraperitoneally and intrarenally (p < 0.05).
Wilcoxon rank test fordifference betweenMSTin animals treated intraperitoneallyand intrarenally
with prednisolone (p < 0.01).
hence local immunosuppression mainly are responsible for the immunosuppres-
sive effect observed. Moreover, the model ofintrarenal drug delivery offers the
possibility to further analyze local regulatory mechanisms in graft rejection and
their response to local immunosuppressive therapy.
The Effect ofLocal Immunosuppressive Therapy on Cellular Infiltration.
￿
Animals,
untreated or treated with prednisolone either intrarenally or intraperitoneally,
were sacrificed at days 3, 7, and 12 after transplantation, and immunohistologic
studies were performed.
Untreated animals showed perivascular and interstitial mononuclear cell infil-
trates at day 3 after transplantation (Table 11). Most ofthe infiltrating cells were
positive for His19, recognizing MHC class II antigens of host type. By day 7
after transplantation, cellular infiltration was clearly increased and intense infil-
tration of MHC class II-positive cells throughout the kidney was observed
associated with marked destruction ofrenal tissue (Fig. 1 a).
In animals treated with prednisolone intraperitoneally (MST, 9 d), cellular
infiltration was somewhat postponed compared with untreated animals. Eventu-
ally, however, at day 7 after transplantation, dense infiltration of MHC class II-
positive cells was observed accompanied by marked destruction ofgrafted tissue.
The histologic picture ofanimals treated intrarenally was completely different
from untreated and intraperitoneally treated rats (Table II). Intrarenally treated
grafts also showed distinct cellular infiltration with MHC class II-positive cells
(Fig. 1 b), however, extensive tissue damage and necrosis were not observed.
For further analysis, the composition of cellular infiltrates in untreated and
treated animals was investigated (Table III). At day 7 after transplantation,
untreated grafts showed cellular infiltrates composed ofTcells and macrophages
(Fig. 1, c and d). T cells were of T helper as well as T cytotoxic/suppressor
phenotype; staining with the mAbs W3/25 and OX8 resulted respectively in a
mean area of infiltration of 28 and 29%, which is a ratio of about 1. Similar
levels and patterns ofinfiltration were found in intraperitoneally treated animals.
Grafts treated intrarenally also showed cellular infiltrates composed of T cellsRUERS ET AL.
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TABLE 11
Immunohistological Observations in Rat Renal Allografts after Various Treatments
Data representconsistent observations made in all rats of the experimental group (n = 4or 5).
* In the BN -> Lewis strain combination, MHCclass II antigens on host cellswere identified with the
mAb His19, whichreacts with the MHC class II antigens of rat strainsof the haplotype L, butnot
with MHCclassII antigens oftheratstrainsofthehaplotypeN. In theBN -"BN strain combination,
MHC class II antigens on infiltrating cells were identified with OX6, which recognizes rat MHC
class 11 antigens ofthe rat strainsof haplotype Land N. Results are expressedas the percentage of
area of the tissue section infiltrated by MHC class I1-positive cells. Data given are mean t SD.
$Examined on routine HandE stainings.
Day after grafting.
and macrophages, however, with a lower percentage of macrophages as com-
pared with untreated animals (Table III, Fig. 1, e and f). Staining with mAbs
W3/25 and OX8 resulted in a mean area of infiltration of 23 and 26%, which is
comparable to untreated animals and also results in a ratio of ^-1 . Thus except
for less infiltration with macrophages, cellular infiltration in intrarenally treated
animals was comparable to untreated or intraperitoneally treated rats.
Effect ofLocal Immunosuppressive Therapyon IL-2-R Expression, IFN-^y Production
and MHC Class II Antigen Induction on Renal Tissue. To further analyze the
positive effects of local immunosuppression on renal allograft rejection, grafts
were stained for IL-2-R expression, the presence of IFN-y, and the expression
of MHC class II antigens on renal tissue (Table II). In untreated animals weak
staining with ART18 and DB 1 could be seen on cells in areas with cellular
infiltration by the third day after transplantation . Serial sections stained with
OX 19 indicated that the cells positive for DB 1 were T lymphocytes, as were the
vast majority of the cells positive for ART18 (data not shown) . On day 7 after
Therapy
Area infil-
trated by
MHC class
11-positive
host cells
(HiSI9+)*
IL-2-R on
infiltrating
cells
(ART18')
Presence of
IFN-y
(DB1*)
MHC class
11 expres-
sion on tu-
bules
(0X6*)
Graft destruc-
tion, edema,
necrosis
hemorrhage,
BN -+ BN
Untreated
Day 7$ 6 ± 1
BN --. Lewis
Untreated
Day 3 15 ± 4 + -
Day7 30 ± 7 + + +++ +++
BN -* Lewis
4 mg/kg i.p.
Day 3 6±1 - - - -
Day 7 33 ± 7 + + ++ ++/+++
BN --* Lewis
4 mg/kg intrarenally
Day 3 5t1 - - -
Day 7 27 ± 6 +
Day 12 20 ± 5 - - -1210
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TABLE III
Phenotypic Composition of the Cellular Infiltrate in Rat Renal Allografts
after Various Treatments
Immunohistological studieswere performed on grafts removed on day 7 after transplantation.
* Data given are mean values ± SD; n = 5.
$Stained simultaneously with W3/25 and OX8.
transplantation the amount of positive cells was significantly increased (Fig. 2, a
and b). At that time, positive cells were scattered throughout the kidney and
were present as isolated cells in the interstitium as well as in cellular infiltrates.
The time course of the induction of MHC class II antigens on renal tissue was
in accordance with the stainings for IFN-y. On day 3, several foci of MHC class
II expression on renal tubules were demonstrated. By the seventh day after
transplantation, MHC class II expression was markedly increased, and distinct
staining of MHC class II antigens on renal tissue was observed (Fig. 2c).
Grafts from animals treated intraperitoneally with prednisolone showed im-
munohistological stainings on day 7 comparable to untreated rats.
Completely different results however were obtained in animals treated intra-
renally (Table II). Grafts from these rats showed almost no staining for IL-2-R
expression and IFN-y, despite the presence of cellular infiltrates (Fig. 3, a-c).
Except for some weak staining on day 7, all stainings with ART18 and DB1 were
negative on day 3 as well as on day 12 after transplantation. These findings
correspond well to the observations made in stainings with OX6. On day 3 and
day 12 after transplantation all kidneys examined failed to show an increase in
MHC class II antigen expression on renal tissue as compared with stainings of
normal nongrafted kidneys (Fig. 3d). Only on day 7 after transplantation were
several small foci of MHC class II antigen expression on renal tissue observed .
However, compared with intraperitoneally treated or untreated grafts this stain-
ing was very weak. From the observations, as summarized in Table 11, we
conclude that intrarenal prednisolone levels interfere with the expression of IL-
2-R, the production of IFN-y, and the induction of MHC class 11 antigen
expression on renal tissue.
Discussion
In this study we demonstrate that intrarenal prednisolone delivery to rat renal
allografts results in high drug levels within the graft combined with low systemic
drug levels. Systemic drug levels were, by themselves, not immunosuppressive,
and local prednisolone levels within the graft proved to be responsible for the
immunosuppressive effect obtained . This experimental model was used to ana-
Percentage of area infiltrated by positive cells*
Therapy OX19
Tcells
W3/25
Th
OX8 (Tc,
Ts)
W3/25 +
OX8$
(Th, Tc,
Ts)
ED2 (mac-
rophages)
BN -~ Lewis untreated 24 ± 6 28 ± 5 29 ± 7 37 ± 6 38 ± 11
BN Lewis 4 mg/kgi.p. 21 1 5 25 ± 6 27 ± 7 37 ± 9 31 ± 8
BN -> Lewis 4 mg/kgintrarenally 20 1 4 23 ± 4 26 ± 6 32 ± 8 18 ± 6RUERS ET AL .
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FIGURE 2 .
￿
Cryostat sections of untreated
grafts removed on day 7 after transplanta-
tion . Sections were stained with mAbs (a)
ART18, (b) DB1, and (c) OX6 . Infiltrating
cells positive for IL-2-R (a) and IFN-f (b)
are scattered throughout the graft. x 100.
Staining with OX6 (c) shows strong induc-
tion of MHC class II antigens on renal tu-
bule cells associated with marked destruc-
tion ofrenal tissue . X 100 .
lyze local events in allograft rejection and their response to immunosuppressive
therapy .
The role oflocal versus systemicimmune processes in cellularimmune response
has been studied in allograft models (30, 32, 46) . These studies report extensive
white cell traffic between the lymphoid tissue and the graft in the early days after
transplantation . After a time, however, the rejection process becomes independ-
ent of the host, and lymphocytes mature and proliferate within the graft, which
implies an essential role for local regulatory mechanismsand hence local produc-
tion oflymphokines .
According to these data, we observed that local treatment of allografts does
not prevent the accumulation of activated white cells within the graft, as occurs1214
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in the early days after transplantation. White cells positive for MHC class II
antigens of host type were equally present in untreated and intrarenally treated
rats. Moreover, the composition of the cellular infiltrate in intrarenally treated
grafts was comparable to the untreated grafts, except for a lower percentage of
infiltrating macrophages. The ratio of W 3/25':OX8+ cells, which is variably
reported to be changed during successful systemic immunosuppressive therapy
(4, 45, 47, 48), was not affected by local treatment. These data show that during
local treatment the systemic responsiveness of the host is normal. Moreover, the
findings confirm that the model of local prednisolone delivery allows the analysis
of intragraft events and their response to local immunosuppressive therapy.
Local treatment was associated with lack of IL-2-R expression, absence of IFN-
y, and inhibition of MHC class 11 induction on renal tissue. Inhibition of these
intragraft events most likely prevented T cells and macrophages present within
the graft from destroying the grafted tissue.
Downregulation of MHC class 11 expression on grafted tissue is postulated to
be an essential mechanism during successful systemic immunosuppressive therapy
(49). In this study the induction of MHC class 11 expression on renal tissue was
inhibited by local treatment, which strongly suggests local regulation of MHC
class 11 expression within the graft. Local regulation of MHC class II expression
in cellular immune response was also postulated by others (50, 51). For example,
Nathan et al. (51) showed that intradermal injection of IFN-y induced local
effects similar to DTH-like hypersensitivity, including MHC class II induction.
The physiologic role of the induction of MHC class 11 antigens on grafted tissue
is most likely the enhancement of antigen presentation to T helper lymphocytes
(15, 16). Inhibition of MHC class II induction may therefore interfere with the
effector mechanisms in graft rejection such as DTH and cell-specific cytotoxicity.
The induction of MHC class II antigens on nonlymphoid tissue is assumed to
result from IFN--y (9-11), although recently also non-IFN-y MHC class II-
inducing factors have been described (52, 53). Steroids were reported to inhibit
the production of IFN-y (18), which explains the absence of this lymphokine in
the presence of high intrarenal drug levels reached in intrarenally treated grafts.
By the inhibition of IFN-y production, prednisolone may indirectly affect the
induction of MHC class 11 antigens on grafted tissue.
It has to be noticed that the absence of IFN-y within the graft may also
contribute to prolongation of graft survival in an other way apart from the
postulated effect on MHC class II expression. IFN-y has been described as an
activating agent for macrophages (54), and the absence of the lymphokine in
certain immune reactions has been associated with reduced macrophage infiltra-
tion and function (51) . We observed a lower percentage of macrophages within
the intrarenally treated grafts; concerning their function however, no direct data
were obtained. It has been postulated that steroids interfere with macrophage
function, e .g., inhibit the production of IL-1 and tumor necrosis factor (55, 56).
To what extent these mechanisms play an essential role during local immunosup-
pressive treatment has to be examined further.
We observed that high local drug levels of prednisolone did not affect the
accumulation of activated (MHC class 11-positive) white cells within the graft,
while the expression of IL-2-R on these cells was clearly inhibited. This obser-1216
￿
GRAFT REJECTION AND LOCAL STEROID DELIVERY
vation is in concordance to Gillis (17), who demonstrated in vitro that steroids
did not prevent cell activation but interfered with IL-2 production. Because IL-
2-R expression is strongly induced by IL-2 (57), high local drug levels within the
graft may interfere with IL-2-R expression by the inhibition of IL-2 production.
The inhibition of IL-2-R expression may be an important mechanism to inhibit
cellular immune response, as is suggested by immunosuppressive therapy with
mAbs against the IL-2-R (58, 59).
In conclusion, intrarenal drug levels most likely did not affect the systemic
immune responsiveness against thegraft, since cellular infiltration in intrarenally
treated grafts was hardly affected. Intrarenal drug levels, however, inhibited
intragraft events such as IL-2-R expression, IFN-y production, and MHC class
II induction on grafted tissue, and in this way prevented rejection. These data
strongly support local independence ofthe cellular immune response within the
graft after a certain time, as suggested by others. Second, the data indicate that
local treatment of allografts can result in effective immunosuppression. Local
manipulation of the immune response by steroids has proven successful in skin
disease and inflammatory lung disease. Although the use ofsteroids in transplan-
tation is also based on their andinflammatory effects, which may be of local as
well as systemic origin (60), local delivery of the drugs to vascularized organ
allografts has hardly been studied, since in man local steroid infusion into the
renal artery of kidney transplants was seriously limited by infections and throm-
bosis (61, 62). Recently, however, new types of oral drugs have been developed
that allow selective treatment of target organs, e.g., liver or kidney, either by
specific tissue binding of the drug or tissue-specific activation (63, 64). The
usefulness ofimmunosuppressive drugs that fulfill these pharmacologic proper-
ties has to be further examined.
Summary
In this report we investigated local regulatory mechanisms in graft rejection
and their response to local immunosuppressive therapy. For this purpose local
immunosuppression was induced in rat kidney allografts by intrarenal infusion
ofprednisolone. Intrarenal drug delivery resulted in high drug levels within the
graft and low systemic drug levels. Systemic drug levels were by themselves not
sufficiently immunosuppressive to induce graft survival, and local prednisolone
levels within thegraftproved to be responsible forprolongation ofgraft survival.
During intrarenal drug delivery, systemic responsiveness to the renal allograft
proved normal, since intrarenally treated grafts were infiltrated by MHC class
II-positive host cells and, except for a somewhat lower percentage of macro-
phages, cellular infiltration in intrarenal treated grafts was comparable to un-
treated grafts. However, T cells and macrophages present in intrarenally treated
grafts were not able to destroy the grafted tissue. Local immunosuppressive
therapy resulted in inhibition of IL-2-R expression, absence of IFN-y, and
prevention of MHC class II induction on grafted tissue. These observations
strongly indicate the presence of local regulatory mechanisms in graft rejection.
The experimental model described can be used for further analysis of these
intragraft events. Moreover, the results demonstrate that local immunosuppres-RUERS ET AL.
￿
1217
sive therapy can contribute to effective inhibition of cellular immune response
in graft rejection.
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